Calmare Therapy Clinical Trial: Diagnosed Diabetic Neuropathy
Calmare Therapy (Scrambler Therapy) to Treat Diagnosed Cases of Diabetic Neuropathy (Pain Resulting from Diabetes) and Reduce Chronic Neuropathic Pain Symptoms
What is Diabetic Neuropathy?
Diabetic neuropathy is a type of nerve damage that can occur as a side effect from diagnosed diabetes. High blood sugar (glucose) can damage nerve fibers throughout your body, but diabetic neuropathy most often damages nerves in the lower extremities (legs and feet) and the hands.
Depending on the affected nerves, symptoms of diabetic neuropathy can range from pain and numbness in the extremities to digestive, urinary tract, blood vessels and heart complications. For some people, these symptoms are mild; for others, diabetic neuropathy can be extremely painful, debilitating and disabling.
Even with stringent blood sugar control and a healthy lifestyle, some diabetic patients still experienced severe chronic pain.
Study Conducted by
Michael J. Cooney, D.C., Clinical Director
Rutherford Allied Medical Group / Calmare Therapy NJ
Location
323 Union Ave., Rutherford, New Jersey (10 miles from New York City)
Study Start Date
Monday, December 5 to Friday, December 16, 2016
Calmare Therapy NJ Background
Calmare Therapy NJ / Rutherford Allied Medical Group, is one of only ten certified providers of Calmare Pain Therapy Treatment®, an FDA-cleared, non-invasive, pain-free, drug-free technology to treat patients suffering from several types of long-term, high-intensity pain.
Since introducing the treatment in 2011, Dr. Cooney has successfully treated more than 500 patients with severe neuropathic pain as a result of injury, surgery or disease.
Scope of the Diabetic Neuropathy Calmare Study
We are conducting a no-cost, 10-treatment (one 35-minute daily therapy session) clinical trial study for pre-qualified patients suffering from diagnosed diabetic neuropathy to determine the efficacy of scrambler therapy as a viable treatment solution for condition-induced neuropathy.
Eligibility Criteria
Selected clinical trial volunteers must be available to undergo a protocol of 10 treatments, once per day, Monday through Friday. We will make every effort to schedule daily appointments at a convenient time for participants.
Travel, daily transportation, meals and accommodations are at the trial participant’s expense
Informed Consent
Clinical trial volunteers who are selected for the study are asked to sign the Informed Consent Form. Signing this document does not require participants to remain for the duration of the study, however.
People can leave the study at any time—either before the study starts or at any time during the study or the follow-up period. The informed consent process continues throughout the study. If new benefits, risks, or side effects are discovered during the study, the researchers must inform the participants.
Publicity
Calmare Therapy NJ reserves the right to publish data about any participant’s trial outcome. We will not include your name or image, at your request.
To Apply / Contact Us / For More Information
To apply for the trial, learn more or ask questions, please contact:
Dr. Michael Cooney
Clinical Director
Calmare Therapy NJ / Rutherford Allied Medical Group
(201) 933.4440 | calmarenj@gmail.com
